問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Taichung Veterans General Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2015-08-14 - 2024-05-01
Condition/Disease
Non-Small Cell Lung Cancer (NSCLC)
Test Drug
Ramucirumab
Participate Sites10Sites
Recruiting5Sites
Terminated4Sites
未分科
2023-05-09 - 2026-07-31
Participate Sites4Sites
Recruiting4Sites
2022-02-01 - 2028-02-15
Participate Sites7Sites
Recruiting7Sites
2021-12-31 - 2024-06-30
Participate Sites3Sites
Recruiting3Sites
2021-11-01 - 2026-02-28
Participate Sites5Sites
Terminated2Sites
2023-11-01 - 2028-12-31
Participate Sites8Sites
Recruiting8Sites
2024-08-01 - 2025-12-31
2020-12-14 - 2025-07-28
Non- Small Cell Lung Cancer
DS-1062a
2020-11-01 - 2024-07-22
2020-09-15 - 2025-10-08
Patritumab Deruxtecan (U3-1402)
全部
